QuidelOrtho to Participate in the 46th Annual Raymond James Institutional Investor Conference
QuidelOrtho (NASDAQ: QDEL), a global provider of innovative in-vitro diagnostic technologies, has announced its participation in the 46th Annual Raymond James Institutional Investor Conference. The company's management team will deliver a presentation on Wednesday, March 5, 2025, at 8:40 a.m. ET / 5:40 a.m. PT.
Investors and interested parties can access both the live webcast and replay of the presentation through the 'Events & Presentations' section on QuidelOrtho's Investor Relations website at https://ir.quidelortho.com. The company specializes in diagnostic technologies for point-of-care settings, clinical labs, and transfusion medicine.
QuidelOrtho (NASDAQ: QDEL), un fornitore globale di tecnologie innovative per la diagnostica in vitro, ha annunciato la sua partecipazione alla 46ª Conferenza Annuale degli Investitori Istituzionali di Raymond James. Il team di gestione dell'azienda presenterà un intervento mercoledì 5 marzo 2025, alle 8:40 a.m. ET / 5:40 a.m. PT.
Investitori e parti interessate possono accedere sia alla diretta streaming che alla registrazione della presentazione attraverso la sezione 'Eventi & Presentazioni' sul sito web delle Relazioni con gli Investitori di QuidelOrtho all'indirizzo https://ir.quidelortho.com. L'azienda è specializzata in tecnologie diagnostiche per contesti di assistenza sanitaria, laboratori clinici e medicina trasfusionale.
QuidelOrtho (NASDAQ: QDEL), un proveedor global de tecnologías innovadoras de diagnóstico in vitro, ha anunciado su participación en la 46ª Conferencia Anual de Inversores Institucionales de Raymond James. El equipo de gestión de la empresa realizará una presentación el miércoles 5 de marzo de 2025, a las 8:40 a.m. ET / 5:40 a.m. PT.
Los inversores y partes interesadas pueden acceder tanto a la transmisión en vivo como a la repetición de la presentación a través de la sección 'Eventos y Presentaciones' en el sitio web de Relaciones con Inversores de QuidelOrtho en https://ir.quidelortho.com. La empresa se especializa en tecnologías de diagnóstico para entornos de atención médica, laboratorios clínicos y medicina transfusional.
QuidelOrtho (NASDAQ: QDEL), 혁신적인 체외 진단 기술을 제공하는 글로벌 기업, 제46회 레이먼드 제임스 기관 투자자 회의에 참여한다고 발표했습니다. 회사의 경영진은 2025년 3월 5일 수요일, 오전 8시 40분 ET / 오전 5시 40분 PT에 발표를 진행할 예정입니다.
투자자 및 관심 있는 분들은 QuidelOrtho의 투자자 관계 웹사이트 https://ir.quidelortho.com의 '이벤트 및 발표' 섹션을 통해 발표의 생중계 및 재생을 모두 이용할 수 있습니다. 이 회사는 진료 현장, 임상 실험실 및 수혈 의학을 위한 진단 기술을 전문으로 하고 있습니다.
QuidelOrtho (NASDAQ: QDEL), un fournisseur mondial de technologies innovantes de diagnostic in vitro, a annoncé sa participation à la 46e Conférence Annuelle des Investisseurs Institutionnels de Raymond James. L'équipe de direction de l'entreprise présentera une intervention le mercredi 5 mars 2025, à 8h40 ET / 5h40 PT.
Les investisseurs et les parties intéressées peuvent accéder à la fois à la diffusion en direct et à la rediffusion de la présentation via la section 'Événements & Présentations' sur le site des Relations avec les Investisseurs de QuidelOrtho à l'adresse https://ir.quidelortho.com. L'entreprise se spécialise dans les technologies de diagnostic pour les soins de santé, les laboratoires cliniques et la médecine transfusionnelle.
QuidelOrtho (NASDAQ: QDEL), ein globaler Anbieter innovativer In-vitro-Diagnosetechnologien, hat seine Teilnahme an der 46. jährlichen Raymond James Institutional Investor Conference angekündigt. Das Management-Team des Unternehmens wird am Mittwoch, den 5. März 2025, um 8:40 Uhr ET / 5:40 Uhr PT eine Präsentation halten.
Investoren und Interessierte können sowohl auf den Live-Stream als auch auf die Wiederholung der Präsentation über den Bereich 'Veranstaltungen & Präsentationen' auf der Investor-Relations-Website von QuidelOrtho unter https://ir.quidelortho.com zugreifen. Das Unternehmen ist auf diagnostische Technologien für die Patientenversorgung, klinische Labore und Transfusionsmedizin spezialisiert.
- None.
- None.
Members of QuidelOrtho’s management team will participate in a presentation at 8:40 a.m. ET / 5:40 a.m. PT.
Interested parties can access the live webcast and replay in the “Events & Presentations” section of the “Investor Relations” page of QuidelOrtho’s website at https://ir.quidelortho.com.
About QuidelOrtho Corporation
QuidelOrtho Corporation (Nasdaq: QDEL) is a world leader in in-vitro diagnostics, developing and manufacturing intelligent solutions that transform data into understanding and action for more people in more places every day.
Offering industry-leading expertise in immunoassay and molecular testing, clinical chemistry and transfusion medicine, bringing fast, accurate and reliable diagnostics when and where they are needed – from home to hospital, lab to clinic. So that patients, clinicians and health officials can spot trends sooner, respond quicker and chart the course ahead with accuracy and confidence.
Building upon its many years of groundbreaking innovation, QuidelOrtho continues to partner with customers across the healthcare continuum and around the globe to forge a new diagnostic frontier. One where insights and solutions know no bounds, expertise seamlessly connects and a more informed path is illuminated for each of us.
Source: QuidelOrtho Corporation
View source version on businesswire.com: https://www.businesswire.com/news/home/20250224654410/en/
Investor Contact:
Juliet Cunningham
Vice President, Investor Relations
IR@quidelortho.com
Media Contact:
D. Nikki Wheeler
Senior Director, Corporate Communications
media@quidelortho.com
Source: QuidelOrtho Corporation
FAQ
When is QuidelOrtho (QDEL) presenting at the Raymond James Conference 2025?
How can investors watch QuidelOrtho's Raymond James Conference presentation?
What type of products does QuidelOrtho (QDEL) specialize in?
Which investor conference is QuidelOrtho (QDEL) participating in March 2025?
